Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. Few studies have investigated the outcome impact of medications interruption and/or modifications following hospital admission. We did consider that it might be interesting to study whether treatment continuation, interruption, and/or re-introduction following ICU admission may modify patients' outcome either in the ICU or following hospital discharge (at 3,6 and 12 months).
Study Type
OBSERVATIONAL
Enrollment
150
No intervention will be performed
Medical Intensive Care Unit, Brest University Hospital
Brest, France
RECRUITINGICU Mortality
Patients mortality will be assessed at the end of the ICU stay (two months)
Time frame: 2 months following ICU Discharge
Hospital mortality
Patients mortality will be assessed at the end of the hospitalisation stay (two months)
Time frame: 2 months following Hospital Discharge
Mortality at Month 3 following discharge
Time frame: 3-months following discharge
Mortality at Month 6 following discharge
Time frame: 6-months following discharge
Mortality at Month 12 (1-year) following discharge
Time frame: 12-months following discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.